Rocket Q3 2026 Adjusted EBITDA Shines, But GAAP and MSR Risks Remain Unaddressed
Read source articleWhat happened
Rocket Companies reported Q3 2026 adjusted revenue of $2.6 billion and adjusted EBITDA of $748 million, claiming share gains in both purchase and refinance despite higher mortgage rates and weaker industry application activity. This follows a fiscal 2025 where GAAP net loss was $234 million but adjusted net income was $628 million, underscoring the gulf between reported and economic earnings. The latest article omits any mention of MSR fair-value changes, which the master report identifies as a primary driver of earnings volatility, with a 20% adverse prepayment-speed shock reducing MSR value by $479 million. While gaining share in a shrinking market is operationally positive, the higher-rate environment contradicts earlier hopes for a sub-6% refi wave and may pressure both origination volumes and MSR valuations, potentially offsetting share wins. Investors should view the adjusted EBITDA figure with caution, as it excludes items like MSR fair-value adjustments, stock-based compensation, and integration costs that are material to true profitability.
Implication
Rocket's share gains in a declining market suggest its servicing-led recapture and partner distribution strategies are working, but the lack of GAAP detail leaves uncertainty about true profitability. The master report's bear case remains live: if rates stay high, origination volumes may not recover, while if rates fall, MSR marks could hurt even as volumes rise. The adjusted EBITDA margin of ~29% is inflated by exclusions, and historical GAAP losses show adjusted figures can be far from economic reality. Key metrics to watch in the upcoming 10-Q include MSR fair-value changes, DTC vs Partner gain-on-sale margins, and service-client recapture rates; without these, the share gain claims are incomplete. Until Rocket reports GAAP net income and shows MSR volatility is contained relative to disclosed sensitivities, investors should not upgrade the thesis beyond WAIT, with attractive entry still near $14.
Thesis delta
The new Q3 data partially validates the operational thesis: share gains in purchase and refinance indicate that Rocket's recapture and distribution efforts are effective even in a tough market. However, the absence of GAAP and MSR details means the core valuation risk—that adjusted profits do not translate to real earnings—is unchanged. The thesis shifts from "prove the refi rebound" to "prove sustainable profitability," as the company demonstrates top-line resilience but still must prove bottom-line durability.
Confidence
Moderate